首页> 外文期刊>Gene therapy >Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes.
【24h】

Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes.

机译:使用新型甘露糖基化阳离子脂质体将甘露糖受体介导的基因转移到巨噬细胞中。

获取原文
获取原文并翻译 | 示例
           

摘要

A novel mannosylated cholesterol derivative, cholesten-5-yloxy-N-(4-((1-imino-2-beta-D-thiomannosyl -ethyl)amino)bu tyl) formamide (Man-C4-Chol), was synthesized in order to perform mannose receptor-mediated gene transfer with liposomes. Plasmid DNA encoding luciferase gene (pCMV-Luc) complexed with liposomes, consisting of a 6:4 mixture of Man-C4-Chol and dioleoylphosphatidylethanolamine (DOPE), showed higher transfection activity than that complexed with 3beta[N-(N', N'-dimethylaminoethane)-carbamoyl]cholesterol (DC-Chol)/DOPE(6:4) and N-[1-(2,3-dioleyloxy)propyl]-N,N,N-trimethylammonium chloride (DOTMA)/DOPE(1:1) liposomes in mouse peritoneal macrophages. The presence of 20 mM mannose significantly inhibited the transfection efficiency of pCMV-Luc complexed with Man-C4-Chol/DC- Chol/DOPE(3:3:4) and Man-C4-Chol/DOPE(6:4) liposomes. High gene expression of pCMV-Luc was observed in the liver after intravenously injecting mice with Man-C4-Chol/DOPE(6:4) liposomes, whereas DC-Chol/DOPE(6:4) liposomes only showed marked expression in the lung. The gene expression with Man-C4-Chol/DOPE(6:4) liposome/ DNA complexes in the liver was observed preferentially in the non-parenchymal cells and was significantly reduced by predosing with mannosylated bovine serum albumin. The gene expression in the liver was greater following intraportal injection. These results suggest that plasmid DNA complexed with mannosylated liposomes exhibits high transfection activity due to recognition by mannose receptors both in vitro and in vivo. Gene Therapy (2000) 7, 292-299.
机译:合成了一种新型的甘露糖基化胆固醇衍生物,胆甾烯基5-酰氧基-N-(4-((1-亚氨基-2-β-D-硫代甘露糖基-乙基)氨基)叔丁基)甲酰胺(Man-C4-Chol)。为了与脂质体进行甘露糖受体介导的基因转移。编码荧光素酶基因(pCMV-Luc)与脂质体复合的质粒DNA,由Man-C4-Chol和二油酰基磷脂酰乙醇胺(DOPE)的6:4混合物组成,比与3beta [N-(N',N '-二甲基氨基乙烷)-氨基甲酰基]胆固醇(DC-Chol)/ DOPE(6:4)和N- [1-(2,3-二环氧乙烷氧基)丙基] -N,N,N-三甲基氯化铵(DOTMA)/ DOPE( 1:1)小鼠腹膜巨噬细胞中的脂质体。 20 mM甘露糖的存在显着抑制了pCMV-Luc与Man-C4-Chol / DC-Chol / DOPE(3:3:4)和Man-C4-Chol / DOPE(6:4)脂质体复合的转染效率。向小鼠静脉注射Man-C4-Chol / DOPE(6:4)脂质体后,在肝脏中观察到pCMV-Luc的高基因表达,而DC-Chol / DOPE(6:4)脂质体仅在肺中显示出明显的表达。优先在非实质细胞中观察到具有Man-C4-Chol / DOPE(6:4)脂质体/ DNA复合物的肝脏中的基因表达,并且通过预先用甘露糖基化的牛血清白蛋白显着降低了该表达。门静脉内注射后,肝脏中的基因表达更高。这些结果表明,与甘露糖基化的脂质体复合的质粒DNA由于在体外和体内都被甘露糖受体识别而表现出高转染活性。基因疗法(2000)7,292-299。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号